1747 related articles for article (PubMed ID: 34669940)
1. Causes and Consequences of Polycystic Ovary Syndrome: Insights From Mendelian Randomization.
Zhu T; Goodarzi MO
J Clin Endocrinol Metab; 2022 Feb; 107(3):e899-e911. PubMed ID: 34669940
[TBL] [Abstract][Full Text] [Related]
2. Investigating the causal impact of polycystic ovary syndrome on gestational diabetes mellitus: a two-sample Mendelian randomization study.
Guixue G; Yifu P; Xiaofeng T; Qian S; Yuan G; Wen Y; Conghui H; Zuobin Z
Front Endocrinol (Lausanne); 2024; 15():1337562. PubMed ID: 38375192
[TBL] [Abstract][Full Text] [Related]
3. Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study.
Harris HR; Cushing-Haugen KL; Webb PM; Nagle CM; Jordan SJ; ; Risch HA; Rossing MA; Doherty JA; Goodman MT; Modugno F; Ness RB; Moysich KB; Kjær SK; Høgdall E; Jensen A; Schildkraut JM; Berchuck A; Cramer DW; Bandera EV; Rodriguez L; Wentzensen N; Kotsopoulos J; Narod SA; McLaughlin JR; Anton-Culver H; Ziogas A; Pearce CL; Wu AH; Lindström S; Terry KL
Int J Epidemiol; 2019 Jun; 48(3):822-830. PubMed ID: 31211375
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer risk in patients with polycystic ovary syndrome: a Mendelian randomization analysis.
Wen Y; Wu X; Peng H; Li C; Jiang Y; Su Z; Liang H; Liu J; He J; Liang W
Breast Cancer Res Treat; 2021 Feb; 185(3):799-806. PubMed ID: 33128677
[TBL] [Abstract][Full Text] [Related]
5. Mendelian randomization analyses for PCOS: evidence, opportunities, and challenges.
Wang C; Wu W; Yang H; Ye Z; Zhao Y; Liu J; Mu L
Trends Genet; 2022 May; 38(5):468-482. PubMed ID: 35094873
[TBL] [Abstract][Full Text] [Related]
6. Is there a shared genetic basis and causal relationship between polycystic ovary syndrome and psychiatric disorders: evidence from a comprehensive genetic analysis.
Jiang X; Deng Q; Stener-Victorin E
Hum Reprod; 2021 Jul; 36(8):2382-2391. PubMed ID: 34051085
[TBL] [Abstract][Full Text] [Related]
7. Causal pathways linking polycystic ovary syndrome to distinct breast cancer subtypes through mediator factors: a multivariable mendelian randomization analysis.
Cao R; Chen L; Liu Y; Wang X; Ma R; Zhao Q; Du Y
J Ovarian Res; 2023 Nov; 16(1):215. PubMed ID: 37957709
[TBL] [Abstract][Full Text] [Related]
8. The causal association between polycystic ovary syndrome and susceptibility and severity of COVID-19: a bidirectional Mendelian randomization study using genetic data.
Si Y; Fei Y; Ma H; Xu Y; Ning L; Li X; Ren Q
Front Endocrinol (Lausanne); 2023; 14():1229900. PubMed ID: 37745707
[TBL] [Abstract][Full Text] [Related]
9. Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis.
Dobbie LJ; Pittam B; Zhao SS; Alam U; Hydes TJ; Barber TM; Cuthbertson DJ
Hum Reprod; 2023 Jun; 38(6):1168-1182. PubMed ID: 37015099
[TBL] [Abstract][Full Text] [Related]
10. Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome.
Brower MA; Hai Y; Jones MR; Guo X; Chen YI; Rotter JI; Krauss RM; Legro RS; Azziz R; Goodarzi MO
Hum Reprod; 2019 Jan; 34(1):127-136. PubMed ID: 30496407
[TBL] [Abstract][Full Text] [Related]
11. Causal relationships between modifiable risk factors and polycystic ovary syndrome: a comprehensive Mendelian randomization study.
Zhao Y; Pang J; Fang X; Yan Z; Yang H; Deng Q; Ma T; Lv M; Li Y; Tu Z; Zou L
Front Endocrinol (Lausanne); 2024; 15():1348368. PubMed ID: 38779450
[TBL] [Abstract][Full Text] [Related]
12. Causal relationship between gut microbiota and polycystic ovary syndrome: a literature review and Mendelian randomization study.
Sun J; Wang M; Kan Z
Front Endocrinol (Lausanne); 2024; 15():1280983. PubMed ID: 38362275
[TBL] [Abstract][Full Text] [Related]
13. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.
Day F; Karaderi T; Jones MR; Meun C; He C; Drong A; Kraft P; Lin N; Huang H; Broer L; Magi R; Saxena R; Laisk T; Urbanek M; Hayes MG; Thorleifsson G; Fernandez-Tajes J; Mahajan A; Mullin BH; Stuckey BGA; Spector TD; Wilson SG; Goodarzi MO; Davis L; Obermayer-Pietsch B; Uitterlinden AG; Anttila V; Neale BM; Jarvelin MR; Fauser B; Kowalska I; Visser JA; Andersen M; Ong K; Stener-Victorin E; Ehrmann D; Legro RS; Salumets A; McCarthy MI; Morin-Papunen L; Thorsteinsdottir U; Stefansson K; ; Styrkarsdottir U; Perry JRB; Dunaif A; Laven J; Franks S; Lindgren CM; Welt CK
PLoS Genet; 2018 Dec; 14(12):e1007813. PubMed ID: 30566500
[TBL] [Abstract][Full Text] [Related]
14. The Association Between Genetically Predicted Systemic Inflammatory Regulators and Polycystic Ovary Syndrome: A Mendelian Randomization Study.
Chen H; Zhang Y; Li S; Tao Y; Gao R; Xu W; Yang Y; Cheng K; Wang Y; Qin L
Front Endocrinol (Lausanne); 2021; 12():731569. PubMed ID: 34646235
[TBL] [Abstract][Full Text] [Related]
15. Body Mass Index and Polycystic Ovary Syndrome: A 2-Sample Bidirectional Mendelian Randomization Study.
Zhao Y; Xu Y; Wang X; Xu L; Chen J; Gao C; Wu C; Pan D; Zhang Q; Zhou J; Chen R; Wang Z; Zhao H; You L; Cao Y; Li Z; Shi Y
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32163573
[TBL] [Abstract][Full Text] [Related]
16. No association effect of genetic polymorphism was observed between polycystic ovary syndrome and cardiovascular diseases risk: a mendelian randomization study.
Zhang X; Huangfu Z; Wang S
Endocrine; 2023 Dec; 82(3):695-706. PubMed ID: 37668928
[TBL] [Abstract][Full Text] [Related]
17. Causal Effects of Genetically Determined Metabolites on Risk of Polycystic Ovary Syndrome: A Mendelian Randomization Study.
Sun S; Jiao M; Han C; Zhang Q; Shi W; Shi J; Li X
Front Endocrinol (Lausanne); 2020; 11():621. PubMed ID: 33013699
[No Abstract] [Full Text] [Related]
18. Polycystic ovary syndrome and 25-hydroxyvitamin D: A bidirectional two-sample Mendelian randomization study.
Zhang N; Liao Y; Zhao H; Chen T; Jia F; Yu Y; Zhu S; Wang C; Zhang W; Liu X
Front Endocrinol (Lausanne); 2023; 14():1110341. PubMed ID: 36967791
[TBL] [Abstract][Full Text] [Related]
19. Polycystic Ovary Syndrome and Risk of Type 2 Diabetes, Coronary Heart Disease, and Stroke.
Zhu T; Cui J; Goodarzi MO
Diabetes; 2021 Feb; 70(2):627-637. PubMed ID: 33158931
[TBL] [Abstract][Full Text] [Related]
20. Maternal Polycystic Ovary Syndrome and Offspring Birth Weight: A Mendelian Randomization Study.
Gan Y; Lu D; Yan C; Zhang J; Zhao J
J Clin Endocrinol Metab; 2022 Mar; 107(4):1020-1029. PubMed ID: 34849988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
